Tamara Minko - Publications

Affiliations: 
Graduate School - Newark Rutgers The State University of New Jersey - Newark, United States 
Area:
Pharmaceutical Chemistry, Physical Chemistry

128 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Rather GM, Anyanwu M, Minko T, Garbuzenko O, Szekely Z, Bertino JR. Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin. Cancers. 13. PMID 33652640 DOI: 10.3390/cancers13050972  0.4
2019 Garbuzenko OB, Kuzmov A, Taratula O, Pine SR, Minko T. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy. Theranostics. 9: 8362-8376. PMID 31754402 DOI: 10.7150/Thno.39816  0.56
2019 Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Advanced Drug Delivery Reviews. PMID 31400350 DOI: 10.1016/J.Addr.2019.07.010  0.56
2019 Zang X, Lee JB, Deshpande KS, Garbuzenko OB, Minko T, Kagan L. Prevention of paclitaxel-induced neuropathy by formulation approach. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30981814 DOI: 10.1016/J.Jconrel.2019.04.013  0.36
2018 Shaik T, Rather GM, Bansal N, Minko T, Garbuzenko O, Szekely Z, Abali EE, Banerjee D, Kerrigan JE, Scotto KW, Bertino JR. Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer. Oncotarget. 9: 33249-33257. PMID 30279956 DOI: 10.18632/Oncotarget.26064  0.4
2018 Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Delivery and Translational Research. 8: 1483-1507. PMID 29978332 DOI: 10.1007/S13346-018-0551-3  0.36
2017 Garbuzenko OB, Ivanova V, Kholodovych V, Reimer DC, Reuhl KR, Yurkow E, Adler D, Minko T. Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s). Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 28434932 DOI: 10.1016/J.Nano.2017.04.005  0.36
2016 Sapiezynski J, Taratula O, Rodriguez-Rodriguez L, Minko T. Precision targeted therapy of ovarian cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27746277 DOI: 10.1016/J.Jconrel.2016.10.014  0.56
2016 Li X, Taratula O, Taratula O, Schumann C, Minko T. LHRH-Targeted Drug Delivery Systems for Cancer Therapy. Mini Reviews in Medicinal Chemistry. PMID 27739358 DOI: 10.2174/1389557516666161013111155  0.56
2016 Savla R, Minko T. Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value. Advanced Drug Delivery Reviews. PMID 27374457 DOI: 10.1016/J.Addr.2016.06.016  0.64
2016 Dorrani M, Garbuzenko OB, Minko T, Michniak-Kohn B. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 228: 150-8. PMID 26965957 DOI: 10.1016/J.Jconrel.2016.03.010  0.56
2015 Yin PT, Shah S, Pasquale NJ, Garbuzenko OB, Minko T, Lee KB. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer. Biomaterials. 81: 46-57. PMID 26720500 DOI: 10.1016/J.Biomaterials.2015.11.023  0.56
2015 Kuzmov A, Minko T. Nanotechnology approaches for inhalation treatment of lung diseases. Journal of Controlled Release : Official Journal of the Controlled Release Society. 219: 500-18. PMID 26297206 DOI: 10.1016/J.Jconrel.2015.07.024  0.56
2015 Shah M, Shah V, Ghosh A, Zhang Z, Minko T. Molecular Inclusion Complexes of β-Cyclodextrin Derivatives Enhance Aqueous Solubility and Cellular Internalization of Paclitaxel: Preformulation and In vitro Assessments. Journal of Pharmaceutics & Pharmacology. 2: 8. PMID 25950011 DOI: 10.13188/2327-204X.1000011  0.32
2014 Garbuzenko OB, Winkler J, Tomassone MS, Minko T. Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 12941-9. PMID 25300552 DOI: 10.1021/La502144Z  0.56
2014 Peddada LY, Garbuzenko OB, Devore DI, Minko T, Roth CM. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 194: 103-12. PMID 25192941 DOI: 10.1016/J.Jconrel.2014.08.023  0.56
2014 Huang X, Tao Z, Praskavich JC, Goswami A, Al-Sharab JF, Minko T, Polshettiwar V, Asefa T. Dendritic silica nanomaterials (KCC-1) with fibrous pore structure possess high DNA adsorption capacity and effectively deliver genes in vitro. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 10886-98. PMID 25188675 DOI: 10.1021/La501435A  0.56
2014 Savla R, Garbuzenko OB, Chen S, Rodriguez-Rodriguez L, Minko T. Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy. Pharmaceutical Research. 31: 3487-502. PMID 24919932 DOI: 10.1007/S11095-014-1436-X  0.56
2014 Garbuzenko OB, Mainelis G, Taratula O, Minko T. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention. Cancer Biology & Medicine. 11: 44-55. PMID 24738038 DOI: 10.7497/J.Issn.2095-3941.2014.01.004  0.56
2014 Xie X, Bansal N, Shaik T, Kerrigan JE, Minko T, Garbuzenko O, Abali EE, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts. Oncotarget. 5: 901-7. PMID 24658650 DOI: 10.18632/Oncotarget.1809  0.56
2014 Huang X, Goswami A, Zou X, Hayes S, Shah V, Minko T, Tao Z, Asefa T. Nanostructured TiO2 Catalyzed Oxidations of Caffeine and Isocaffeine and Their Cytotoxicity and Genotoxicity Towards Ovarian Cancer Cells Bionanoscience. 4: 27-36. DOI: 10.1007/S12668-013-0120-7  0.56
2014 Jain RN, Huang X, Das S, Silva R, Ivanova V, Minko T, Asefa T. Functionalized mesoporous silica nanoparticles for glucose- and pH-stimulated release of insulin Zeitschrift Fur Anorganische Und Allgemeine Chemie. 640: 616-623. DOI: 10.1002/Zaac.201300604  0.56
2013 Minko T. Nanotechnology and drug resistance. Advanced Drug Delivery Reviews. 65: 1665-6. PMID 24177352 DOI: 10.1016/J.Addr.2013.10.005  0.56
2013 Minko T, Rodriguez-Rodriguez L, Pozharov V. Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Advanced Drug Delivery Reviews. 65: 1880-95. PMID 24120655 DOI: 10.1016/J.Addr.2013.09.017  0.56
2013 Shah V, Taratula O, Garbuzenko OB, Taratula OR, Rodriguez-Rodriguez L, Minko T. Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6193-204. PMID 24036854 DOI: 10.1158/1078-0432.Ccr-13-1536  0.56
2013 Savla R, Minko T. Nanotechnology approaches for inhalation treatment of fibrosis. Journal of Drug Targeting. 21: 914-25. PMID 23978292 DOI: 10.3109/1061186X.2013.829078  0.56
2013 Minko T, Hatefi A. Preface-tenth international nanomedicine and drug delivery symposium (NanoDDS'12). Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 259-60. PMID 23954371 DOI: 10.1016/J.Jconrel.2013.08.008  0.56
2013 Xie X, Kerrigan JE, Minko T, Garbuzenko O, Lee KC, Scarborough A, Abali EE, Budak-Alpdogan T, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer. Cancer Biology & Therapy. 14: 742-51. PMID 23792570 DOI: 10.4161/Cbt.25184  0.56
2013 Taratula O, Kuzmov A, Shah M, Garbuzenko OB, Minko T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 349-57. PMID 23648833 DOI: 10.1016/J.Jconrel.2013.04.018  0.56
2013 Mainelis G, Seshadri S, Garbuzenko OB, Han T, Wang Z, Minko T. Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26: 345-54. PMID 23530772 DOI: 10.1089/Jamp.2011-0966  0.56
2013 Ivanova V, Garbuzenko OB, Reuhl KR, Reimer DC, Pozharov VP, Minko T. Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 84: 335-44. PMID 23228437 DOI: 10.1016/J.Ejpb.2012.11.023  0.56
2013 Shah V, Taratula O, Garbuzenko OB, Patil ML, Savla R, Zhang M, Minko T. Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids. Current Drug Discovery Technologies. 10: 8-15. PMID 22564170 DOI: 10.2174/1570163811310010003  0.56
2012 Hatefi A, Minko T. Advances in image-guided drug delivery. Drug Delivery and Translational Research. 2: 1-2. PMID 25786596 DOI: 10.1007/S13346-011-0057-8  0.56
2012 Zhang M, Garbuzenko OB, Reuhl KR, Rodriguez-Rodriguez L, Minko T. Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases. Nanomedicine (London, England). 7: 185-97. PMID 22339132 DOI: 10.2217/Nnm.11.131  0.56
2012 Sheihet L, Garbuzenko OB, Bushman J, Gounder MK, Minko T, Kohn J. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 45: 320-9. PMID 22155544 DOI: 10.1016/J.Ejps.2011.11.017  0.56
2011 Nadler-Milbauer M, Apter L, Haupt Y, Haupt S, Barenholz Y, Minko T, Rubinstein A. Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer. Journal of Drug Targeting. 19: 859-73. PMID 22082104 DOI: 10.3109/1061186X.2011.622401  0.56
2011 Taratula O, Garbuzenko OB, Chen AM, Minko T. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. Journal of Drug Targeting. 19: 900-14. PMID 21981718 DOI: 10.3109/1061186X.2011.622404  0.56
2011 Dayan N, Shah V, Minko T. Preliminary evaluation of the genotoxic potential of a hydrophilic polymer with three preservation systems International Journal of Cosmetic Science. 33: 497-502. PMID 21696404 DOI: 10.1111/J.1468-2494.2011.00661.X  0.56
2011 Betigeri S, Zhang M, Garbuzenko O, Minko T. Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage. Drug Delivery and Translational Research. 1: 13-24. PMID 21461383 DOI: 10.1007/S13346-010-0003-1  0.56
2011 Dayan N, Shah V, Minko T. Genotoxic potential evaluation of a cosmetic insoluble substance by the micronuclei assay Journal of Cosmetic Science. 62: 29-39. PMID 21443843  0.56
2011 Savla R, Taratula O, Garbuzenko O, Minko T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 153: 16-22. PMID 21342659 DOI: 10.1016/J.Jconrel.2011.02.015  0.56
2011 Patil ML, Zhang M, Minko T. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. Acs Nano. 5: 1877-87. PMID 21322531 DOI: 10.1021/Nn102711D  0.56
2011 Taratula O, Garbuzenko O, Savla R, Wang YA, He H, Minko T. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Current Drug Delivery. 8: 59-69. PMID 21034421 DOI: 10.2174/156720111793663642  0.56
2011 Taratula O, Savla R, He H, Minko T. Poly(propyleneimine) dendrimers as potential siRNA delivery nanocarrier: From structure to function International Journal of Nanotechnology. 8: 36-52. DOI: 10.1504/Ijnt.2011.037169  0.56
2011 Minko T, Khandare JJ, Jayant S. Polymeric Drugs Macromolecular Engineering: Precise Synthesis, Materials Properties, Applications. 4: 2541-2595. DOI: 10.1002/9783527631421.ch61  0.56
2011 Dayan N, Shah V, Minko T. Correlation between cell viability and DNA damage: Studying chromosomal effect of cosmetic substances Journal of Cosmetic Science. 62: 70-71.  0.56
2010 Christian DA, Garbuzenko OB, Minko T, Discher DE. Polymer Vesicles with a Red Cell-like Surface Charge: Microvascular Imaging and in vivo Tracking with Near-Infrared Fluorescence. Macromolecular Rapid Communications. 31: 135-41. PMID 21590885 DOI: 10.1002/Marc.200900589  0.56
2010 Chandna P, Khandare JJ, Ber E, Rodriguez-Rodriguez L, Minko T. Multifunctional tumor-targeted polymer-peptide-drug delivery system for treatment of primary and metastatic cancers. Pharmaceutical Research. 27: 2296-306. PMID 20700631 DOI: 10.1007/S11095-010-0235-2  0.56
2010 Chen AM, Taratula O, Wei D, Yen HI, Thomas T, Thomas TJ, Minko T, He H. Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. Acs Nano. 4: 3679-88. PMID 20521827 DOI: 10.1021/Nn901796N  0.56
2010 Garbuzenko OB, Saad M, Pozharov VP, Reuhl KR, Mainelis G, Minko T. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proceedings of the National Academy of Sciences of the United States of America. 107: 10737-42. PMID 20498076 DOI: 10.1073/Pnas.1004604107  0.56
2010 Minko T, Patil ML, Zhang M, Khandare JJ, Saad M, Chandna P, Taratula O. LHRH-targeted nanoparticles for cancer therapeutics. Methods in Molecular Biology (Clifton, N.J.). 624: 281-94. PMID 20217603 DOI: 10.1007/978-1-60761-609-2_19  0.56
2010 Minko T. HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance. Advanced Drug Delivery Reviews. 62: 192-202. PMID 20005272 DOI: 10.1016/J.Addr.2009.12.002  0.56
2010 Cai S, Christian DA, Tewari M, Minko T, Discher DE. Anti-cancer polymersomes Rsc Nanoscience and Nanotechnology. 300-312.  0.56
2009 Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small (Weinheim An Der Bergstrasse, Germany). 5: 2673-7. PMID 19780069 DOI: 10.1002/Smll.200900621  0.56
2009 Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, He H, Minko T. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 140: 284-93. PMID 19567257 DOI: 10.1016/J.Jconrel.2009.06.019  0.56
2009 Christian DA, Cai S, Garbuzenko OB, Harada T, Zajac AL, Minko T, Discher DE. Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Molecular Pharmaceutics. 6: 1343-52. PMID 19249859 DOI: 10.1021/Mp900022M  0.56
2009 Patil ML, Zhang M, Taratula O, Garbuzenko OB, He H, Minko T. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules. 10: 258-66. PMID 19159248 DOI: 10.1021/Bm8009973  0.56
2009 Garbuzenko OB, Saad M, Betigeri S, Zhang M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP, Minko T. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug. Pharmaceutical Research. 26: 382-94. PMID 18958402 DOI: 10.1007/S11095-008-9755-4  0.56
2009 Keresztessy Z, Bodnár M, Ber E, Hajdu I, Zhang M, Hartmann JF, Minko T, Borbély J. Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery Colloid and Polymer Science. 287: 759-765. DOI: 10.1007/S00396-009-2022-3  0.56
2009 Taratula O, Savla R, Pandya I, Wang A, Minko T, He H. Novel superparamagnetic iron oxide nanoparticles for a multifunctional nanomedicine platform Materials Research Society Symposium Proceedings. 1140: 93-98.  0.56
2009 Taratula O, Kirkpatrick P, Savla R, Pandya I, Minko T, He H. Surface engineering for in vivo targeting delivery of siRNA for efficient cancer therapy Materials Research Society Symposium Proceedings. 1140: 65-71.  0.56
2008 Saad M, Garbuzenko OB, Minko T. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine (London, England). 3: 761-76. PMID 19025451 DOI: 10.2217/17435889.3.6.761  0.56
2008 Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? Journal of Controlled Release : Official Journal of the Controlled Release Society. 130: 107-14. PMID 18582982 DOI: 10.1016/J.Jconrel.2008.05.024  0.56
2008 Patil ML, Zhang M, Betigeri S, Taratula O, He H, Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjugate Chemistry. 19: 1396-403. PMID 18576676 DOI: 10.1021/Bc8000722  0.56
2008 Wang Y, Saad M, Pakunlu RI, Khandare JJ, Garbuzenko OB, Vetcher AA, Soldatenkov VA, Pozharov VP, Minko T. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3607-16. PMID 18519795 DOI: 10.1158/1078-0432.Ccr-07-2020  0.56
2008 Chen AM, Taratula O, Wei D, Minko T, He H. Labile catalytic packaging and delivering of short interference RNA to cancer cells: Control of gold nanoparticles "out" of siRNA complexes Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 342-345.  0.56
2008 Taratula O, Kirkpatrick P, Savla R, Pandya I, Minko T, He H. Toward in vivo targeting delivery of siRNA for efficient cancer therapy Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 346-349.  0.56
2008 Taratula O, Savia R, Pandya I, Geng H, Wang A, Minko T, He H. Multifunctional siRNA delivery system for cancer therapy Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 49-52.  0.56
2007 Minko T. Intracellular delivery. Pharmaceutical Research. 24: 2097-8. PMID 17762915 DOI: 10.1007/s11095-007-9422-1  0.56
2007 Chandna P, Saad M, Wang Y, Ber E, Khandare J, Vetcher AA, Soldatenkov VA, Minko T. Targeted proapoptotic anticancer drug delivery system. Molecular Pharmaceutics. 4: 668-78. PMID 17685579 DOI: 10.1021/Mp070053O  0.56
2007 Zalipsky S, Saad M, Kiwan R, Ber E, Yu N, Minko T. Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action. Journal of Drug Targeting. 15: 518-30. PMID 17671898 DOI: 10.1080/10611860701499946  0.56
2007 Jayant S, Khandare JJ, Wang Y, Singh AP, Vorsa N, Minko T. Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment. Pharmaceutical Research. 24: 2120-30. PMID 17668297 DOI: 10.1007/S11095-007-9406-1  0.56
2007 Bodnar M, Minko T, Hartmann JF, Borbely J. Fluorescent nanoparticles based on chitosan 2007 Nsti Nanotechnology Conference and Trade Show - Nsti Nanotech 2007, Technical Proceedings. 2: 279-282.  0.56
2006 Khandare JJ, Minko T. Antibodies and peptides in cancer therapy. Critical Reviews in Therapeutic Drug Carrier Systems. 23: 401-35. PMID 17425513 DOI: 10.1615/Critrevtherdrugcarriersyst.V23.I5.20  0.56
2006 Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjugate Chemistry. 17: 1464-72. PMID 17105225 DOI: 10.1021/Bc060240P  0.56
2006 Minko T, Pakunlu RI, Wang Y, Khandare JJ, Saad M. New generation of liposomal drugs for cancer. Anti-Cancer Agents in Medicinal Chemistry. 6: 537-52. PMID 17100558 DOI: 10.2174/187152006778699095  0.56
2006 Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. Journal of Controlled Release : Official Journal of the Controlled Release Society. 116: 150-8. PMID 16942814 DOI: 10.1016/J.Jconrel.2006.07.012  0.56
2006 Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. Journal of Controlled Release : Official Journal of the Controlled Release Society. 114: 153-62. PMID 16889867 DOI: 10.1016/J.Jconrel.2006.06.010  0.56
2006 Betigeri S, Pakunlu RI, Wang Y, Khandare JJ, Minko T. JNK1 as a molecular target to limit cellular mortality under hypoxia. Molecular Pharmaceutics. 3: 424-30. PMID 16889436 DOI: 10.1021/Mp060014X  0.56
2006 Ahmed F, Pakunlu RI, Srinivas G, Brannan A, Bates F, Klein ML, Minko T, Discher DE. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Molecular Pharmaceutics. 3: 340-50. PMID 16749866 DOI: 10.1021/Mp050103U  0.56
2006 Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Pakunlu RI. Chronic hypoxia in Andeans; are there lessons for neurology at sea level? Journal of the Neurological Sciences. 247: 93-9. PMID 16733057 DOI: 10.1016/J.Jns.2006.03.021  0.56
2006 Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Wang Y. Gene expression, autonomic function and chronic hypoxia:lessons from the Andes. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 16: 217-22. PMID 16583294 DOI: 10.1007/S10286-006-0338-3  0.56
2006 Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T. Novel polymeric prodrug with multivalent components for cancer therapy. The Journal of Pharmacology and Experimental Therapeutics. 317: 929-37. PMID 16469865 DOI: 10.1124/Jpet.105.098855  0.56
2006 Dharap SS, Chandna P, Wang Y, Khandare JJ, Qiu B, Stein S, Minko T. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy. The Journal of Pharmacology and Experimental Therapeutics. 316: 992-8. PMID 16291730 DOI: 10.1124/Jpet.105.094243  0.56
2006 Khandare J, Minko T. Polymer-drug conjugates: Progress in polymeric prodrugs Progress in Polymer Science (Oxford). 31: 359-397. DOI: 10.1016/J.Progpolymsci.2005.09.004  0.56
2005 Minko T. Soluble polymer conjugates for drug delivery. Drug Discovery Today. Technologies. 2: 15-20. PMID 24981750 DOI: 10.1016/J.Ddtec.2005.05.005  0.56
2005 Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Wang Y. Migraine in the Andes and headache at sea level Cephalalgia. 25: 1117-1121. PMID 16305600 DOI: 10.1111/J.1468-2982.2005.00973.X  0.56
2005 Yu D, Peng P, Dharap SS, Wang Y, Mehlig M, Chandna P, Zhao H, Filpula D, Yang K, Borowski V, Borchard G, Zhang Z, Minko T. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 110: 90-102. PMID 16271793 DOI: 10.1016/J.Jconrel.2005.09.050  0.56
2005 Minko T, Wang Y, Pozharov V. Remediation of cellular hypoxic damage by pharmacological agents. Current Pharmaceutical Design. 11: 3185-99. PMID 16178753 DOI: 10.2174/1381612054864948  0.56
2005 Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide Proceedings of the National Academy of Sciences of the United States of America. 102: 12962-12967. PMID 16123131 DOI: 10.1073/Pnas.0504274102  0.56
2005 Minko T, Batrakova EV, Li S, Li Y, Pakunlu RI, Alakhov VY, Kabanov AV. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 105: 269-78. PMID 15939500 DOI: 10.1016/J.Jconrel.2005.03.019  0.56
2005 Ahmed F, Pakunlu RI, Srinivas G, Klein ML, Minko T, Discher DE. Degradable polymersomes that create new pathways for anti-cancer drugs Aiche Annual Meeting, Conference Proceedings. 14292.  0.56
2004 Wang Y, Pakunlu RI, Tsao W, Pozharov V, Minko T. Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis. Molecular Pharmaceutics. 1: 156-65. PMID 15832512 DOI: 10.1021/Mp034031N  0.56
2004 Wang Y, Minko T. A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug. Biochemical Pharmacology. 68: 2031-42. PMID 15476674 DOI: 10.1016/J.Bcp.2004.07.017  0.56
2004 Pakunlu RI, Wang Y, Tsao W, Pozharov V, Cook TJ, Minko T. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system. Cancer Research. 64: 6214-24. PMID 15342407 DOI: 10.1158/0008-5472.Can-04-0001  0.56
2004 Minko T, Dharap SS, Pakunlu RI, Wang Y. Molecular targeting of drug delivery systems to cancer Current Drug Targets. 5: 389-406. PMID 15134222 DOI: 10.2174/1389450043345443  0.56
2004 Jin S, Mathis AS, Gioia K, Minko T, Friedman GS, Rosenblatt J, Peng F, Serur DS, Knipp GT. Effect of tacrolimus on the expression of macrophage scavenger and nuclear hormone receptors in THP-1-derived human macrophages. Transplantation. 77: 1281-7. PMID 15114099 DOI: 10.1097/01.Tp.0000120950.16995.20  0.56
2004 Jin S, Mathis AS, Rosenblatt J, Minko T, Friedman GS, Gioia K, Serur DS, Knipp GT. Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: macrophage scavenger receptor regulation. Transplantation. 77: 497-504. PMID 15084924 DOI: 10.1097/01.Tp.0000109690.44426.20  0.56
2004 Minko T. Drug targeting to the colon with lectins and neoglycoconjugates. Advanced Drug Delivery Reviews. 56: 491-509. PMID 14969755 DOI: 10.1016/J.Addr.2003.10.017  0.56
2004 David A, Kopecková P, Minko T, Rubinstein A, Kopecek J. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. European Journal of Cancer (Oxford, England : 1990). 40: 148-57. PMID 14687799 DOI: 10.1016/J.Ejca.2003.07.001  0.56
2003 Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. Journal of Controlled Release : Official Journal of the Controlled Release Society. 91: 61-73. PMID 12932638 DOI: 10.1016/S0168-3659(03)00209-8  0.56
2003 Dharap SS, Minko T. Targeted proapoptotic LHRH-BH3 peptide. Pharmaceutical Research. 20: 889-96. PMID 12817893 DOI: 10.1023/A:1023839319950  0.56
2003 Minko T, Dharap SS, Fabbricatore AT. Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense. Cancer Detection and Prevention. 27: 193-202. PMID 12787726 DOI: 10.1016/S0361-090X(03)00067-9  0.56
2003 Peterson CM, Shiah JG, Sun Y, Kopecková P, Minko T, Straight RC, Kopecek J. HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer. Advances in Experimental Medicine and Biology. 519: 101-23. PMID 12675211 DOI: 10.1007/0-306-47932-X_7  0.56
2003 Pakunlu RI, Cook TJ, Minko T. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin. Pharmaceutical Research. 20: 351-9. PMID 12669953 DOI: 10.1023/A:1022687617318  0.56
2003 Appenzeller O, Minko T, Pozharov V, Bonfichi M, Malcovati L, Gamboa J, Bernardi L. Gene expression in the Andes; relevance to neurology at sea level. Journal of the Neurological Sciences. 207: 37-41. PMID 12614929 DOI: 10.1016/S0022-510X(02)00356-8  0.56
2003 Nichols WK, Mehta R, Skordos K, Macé K, Pfeifer AM, Carr BA, Minko T, Burchiel SW, Yost GS. 3-methylindole-induced toxicity to human bronchial epithelial cell lines. Toxicological Sciences : An Official Journal of the Society of Toxicology. 71: 229-36. PMID 12563108 DOI: 10.1093/Toxsci/71.2.229  0.56
2002 Minko T, Stefanov A, Pozharov V. Selected contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal alpha-tocopherol. Journal of Applied Physiology (Bethesda, Md. : 1985). 93: 1550-60; discussion . PMID 12235059 DOI: 10.1152/Japplphysiol.00007.2002  0.56
2002 Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, Stein S, Sinko PJ. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 50: 143-50. PMID 12172980 DOI: 10.1007/S00280-002-0463-1  0.56
2001 Kasuya Y, Lu ZR, Kopečková P, Minko T, Tabibi SE, Kopeček J. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates Journal of Controlled Release. 74: 203-211. PMID 11489496 DOI: 10.1016/S0168-3659(01)00318-2  0.56
2001 Kopeček J, Kopečková P, Minko T, Lu ZR, Peterson CM. Water soluble polymers in tumor targeted delivery Journal of Controlled Release. 74: 147-158. PMID 11489491 DOI: 10.1016/S0168-3659(01)00330-3  0.56
2001 Minko T, Kopečková P, Kopeček J. Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells Journal of Controlled Release. 71: 227-237. PMID 11295216 DOI: 10.1016/S0168-3659(01)00220-6  0.56
2001 Minko T, Kopekov P, Kopeek J. Immunoprotective therapy with targeted anticancer drugs Macromolecular Symposia. 172: 21-28. DOI: 10.1002/1521-3900(200107)172:1<21::AID-MASY21>3.0.CO;2-C  0.56
2001 Minko T, Dharap SS, Pakunlu RI, Colaizzi JL. Advanced drug delivery systems in cancer chemotherapy Disease Management and Clinical Outcomes. 3: 48-54.  0.56
2000 Wang D, Kopečková P, Minko T, Nanayakkara V, Kopeček J. Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: Potential drug carriers Biomacromolecules. 1: 313-319. PMID 11710118 DOI: 10.1021/Bm0000236  0.56
2000 Demoy M, Minko T, Kopečková P, Kopeček J. Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells Journal of Controlled Release. 69: 185-196. PMID 11018556 DOI: 10.1016/S0168-3659(00)00301-1  0.56
2000 Minko T, Kopeckova P, Pozharov V, Jensen KD, Kopecek J. The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in resistant solid tumors. Pharmaceutical Research. 17: 505-14. PMID 10888300 DOI: 10.1023/A:1007500412442  0.56
2000 Kopeček J, Kopečková P, Minko T, Lu ZR. HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action European Journal of Pharmaceutics and Biopharmaceutics. 50: 61-81. PMID 10840193 DOI: 10.1016/S0939-6411(00)00075-8  0.56
2000 Minko T, Kopečková P, Kopeček J. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma International Journal of Cancer. 86: 108-117. PMID 10728603 DOI: 10.1002/(Sici)1097-0215(20000401)86:1<108::Aid-Ijc17>3.0.Co;2-8  0.56
2000 Kunath K, Kopečková P, Minko T, Kopeček J. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound Adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line European Journal of Pharmaceutics and Biopharmaceutics. 49: 11-15. PMID 10613922 DOI: 10.1016/S0939-6411(99)00033-8  0.56
2000 Wang D, Kapečková P, Minko T, Nanayakkara V, Kopeček J. Synthesis of star-like poly[N-(2-hydroxypropyl)methacrylamide] using PAMAM dendrimer as the core American Chemical Society, Polymer Preprints, Division of Polymer Chemistry. 41: 994-995.  0.56
1999 Minko T, Kopečková P, Kopeček J. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells Pharmaceutical Research. 16: 986-996. PMID 10450921 DOI: 10.1023/A:1018959029186  0.56
1999 Minko T, Kopečková P, Kopeček J. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line Journal of Controlled Release. 59: 133-148. PMID 10332049 DOI: 10.1016/S0168-3659(98)00186-2  0.56
1999 Choi WM, Kopečková P, Minko T, Kopeček J. Synthesis of HPMA copolymer containing adriamycin bound via an acid- labile spacer and its activity toward human ovarian carcinoma cells Journal of Bioactive and Compatible Polymers. 14: 447-456. DOI: 10.1177/088391159901400601  0.56
1999 Kopecek J, Kopeckova P, Minko T. HPMA copolymer-bound anticancer drugs: Mechanism of action on cellular and subcellular levels Proceedings of the Controlled Release Society. 24-25.  0.56
1999 Minko T, Kopeckova P, Kopecek J. EPR effect, multidrug resistance and the efficacy of HPMA copolymer-bound adriamycin in solid tumors with high vascularization Proceedings of the Controlled Release Society. 46-47.  0.56
1998 Minko T, Kopečková P, Pozharov V, Kopeček J. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line Journal of Controlled Release. 54: 223-233. PMID 9724909 DOI: 10.1016/S0168-3659(98)00009-1  0.56
1998 Minko T, Kopeckova P, Pozharov V, Kopecek J. Peculiarities of apoptosis induction and cell metabolism in human ovarian carcinoma cell lines exposed to free and HPMA copolymer bound adriamycin Proceedings of the Controlled Release Society. 99-100.  0.56
Show low-probability matches.